Dr. Michael D. Ruff has recently been appointed vice president of pharmaceutical development at Metrics, Inc. He recently received his clinical doctor of pharmacy degree from the Shenandoah University Bernard J. Dunn College of Pharmacy.

Dr. Ruff completed his Pharm.D. degree shortly after becoming the ninth person in the world to earn the new Certified Pharmaceutical Industry Professional (CPIP) credential, awarded by the International Society for Pharmaceutical Engineering’s Professional Certification Commission and is the first competency-based international certification for pharmaceutical professionals. Those who qualify for the credential demonstrate global competency through education, experience and rigorous examination.

Dr. Ruff has been with Metrics for 11 years, where his responsibilities have included providing formulation development, clinical trial material manufacture and consultation services to clients. “In his many years here at Metrics, Mike has consistently demonstrated a personal commitment to excellence, including his pursuit of continuing education that allows him to remain at the forefront of industry knowledge and technology,” said Phil Hodges, president. “We congratulate Mike on earning his doctorate.”

Dr. Ruff has been a member of ISPE since 2005 and is a registered pharmacist with more than 20 years’ experience in developing new chemical entities with a focus on oncology, central nervous system and anti-viral drugs. He holds several U.S. patents for pharmaceutical applications and has authored numerous technical papers. He also is a member of the American Association of Pharmaceutical Scientists.